Quarterly report pursuant to Section 13 or 15(d)

Shareholders??? Equity (Details Narrative)

Shareholders’ Equity (Details Narrative) - USD ($)					3 Months Ended			9 Months Ended
Shareholders’ Equity (Details Narrative) - USD ($)	Sep. 05, 2024	Sep. 04, 2024	Jun. 25, 2024	Mar. 01, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2024	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares sold								5,600,000
Gross proceeds from shares sold								$ 7,700,000
Common stock, par value					$ 0.001			$ 0.001	$ 0.001
Gross proceeds of offering percentage								7.00%
Common stock, shares issued	8,659,071				9,387,547			9,387,547	3,080,693
Common stock, shares outstanding	8,659,071				9,387,547			9,387,547	3,080,693
Warrants shares outstanding					1,887,167			1,887,167
Proceeds from offering								$ 4,450,000
ONP-002 Product [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from offering								$ 3,790,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued	3,078,378				3,806,854	1,100,000	1,400,000
Warrants to purchase shares of common stock	5,028,206
Pre-Funded Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants shares outstanding	5,028,206
Number of shares acquire	5,028,206
Warrants shares exercised	3,888,501
Warrants shares unexercised	1,139,705
Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of warrants exercise price								125.00%
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Legal fees								$ 125,000
Maximum [Member] \| Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of aggregate number of securities sold								5.00%
Underwriting Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares sold				1,400,000
Shares sold price per share to public				$ 1.50
Shares sold price per share to underwriter				$ 1.395
Option granted to purchase common shares				210,000
Warrant issuance description				The Company also agreed to issue warrants to the designees of the Representative exercisable one hundred eighty (180) days after February 27, 2024 and expiring on February 27, 2029, to purchase up to 5% of the shares sold through the Underwriting Agreement at an exercise price of $1.875 per share
Warrant exercisable date				Feb. 27, 2024
Warrant maturity date				Feb. 27, 2029
Exercise price per share				$ 1.875
Gross proceeds from shares sold				$ 2,100,000
Placement Agency Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares sold			1,100,000
Common stock, par value			$ 0.001
Offering price per share			$ 1.00
Gross proceeds of offering percentage			7.00%
Gross proceeds of amount before underwriting discounts and commissions and other expenses payable			$ 1,100,000
Placement Agency Agreement [Member] \| Dawson James Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of warrants exercise price			125.00%
Placement Agency Agreement [Member] \| Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Legal fees			$ 75,000
Placement Agency Agreement [Member] \| Maximum [Member] \| Dawson James Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of aggregate number of securities sold			5.00%
Second Placement Agency Agreement [Member] \| Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares sold		8,106,584
Common stock, par value		$ 0.001
Offering price per share		0.55
Second Placement Agency Agreement [Member] \| Pre-Funded Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price per share		0.001
Offering price per share		$ 0.549